Category Science and Technology
Join the Debate on Human Genome Editing!
Yeyang Su invites Impact Ethics readers to mark their calendars for the second International Summit on Human Genome Editing.
Pharmacare: Improving Access to Expensive Drugs
Marc-André Gagnon dispels misconceptions about the benefits of private health insurance plans and argues in favour of a universal model for pharmacare.
The Privacy Implications of Human DNA Sequencing
Landon J. Getz explores the privacy minefield of commercial DNA Sequencing, and how it has become relevant in recent news.
Talking about decriminalization is not enough
Katie Hammond argues that discussions surrounding the Assisted Human Reproduction Act must go beyond decriminalization.
My FDA-approved Buckle: A Regulated Intervention
Michele Battle-Fisher calls for deeper ethical scrutiny of unregulated and experimental medical interventions.
The Ethics of Apps
Dylan Roskams-Edris warns about the habit forming and addictive capacities of smartphone apps and explains the need for an ethics of apps.
New ART regulations require feminist voices
Francine Coeytux, Marcy Darnovsky, Susan Berke Fogel, and Emily Galpern maintain that the development of new regulations about assisted reproductive technologies must include the voices of scholars who have studied women’s health issues, and advocates who have worked for policies and practices that safeguard women’s health and rights.
